Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 13, 2026
Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Key Takeaways

  • RCAT shares are falling approximately 13% in premarket trading on May 13, 2026, following the announcement of a $200 million stock offering that threatens significant shareholder dilution
  • The equity offering is the primary catalyst, unveiled before the market open and immediately pressuring the stock
  • A recent Q1 2026 earnings report (released May 7) added an overhang: revenue of $15.5 million missed the FactSet consensus estimate of $17.6 million, and EPS of -$0.22 badly missed the -$0.12 estimate
  • Despite record 849% year-over-year revenue growth driven by U.S. Army drone contracts, profitability and margin concerns remain front and center for investors
  • Shares had already closed Tuesday at $11.03, down nearly 2% on the day, suggesting the stock was under pressure even before the offering news broke
  • Traders are watching the size and pricing of the offering, any use-of-proceeds disclosures, and whether institutional demand is sufficient to absorb the new shares

Opening Summary

Red Cat Holdings (RCAT) is a Puerto Rico-based aerospace and defense company that designs and manufactures tactical drone systems — including its flagship Black Widow small unmanned aerial system (sUAS) — for the U.S. military, NATO allies, and government security agencies. Shares are tumbling roughly 13% in premarket trading on May 13, 2026, declining from Tuesday's closing price of $11.03 to approximately $9.60. The selloff is driven by the company's announcement of a $200 million stock offering, a capital raise that markets are pricing as a dilutive event for existing shareholders at a time when the stock's recent earnings report had already disappointed expectations.

$200 Million Stock Offering Triggers Dilution Selloff

The dominant catalyst for the sharp premarket decline is Red Cat's announcement of a $200 million equity offering, disclosed before Wednesday's opening bell. Stock offerings of this scale are routinely met with selling pressure because they increase the total share count outstanding, diluting the ownership percentage and earnings per share attributable to current investors. The size of the raise is especially notable given the company's current market capitalization, making the dilution particularly pronounced relative to its existing equity base. Investors are reacting by selling ahead of the pricing of the deal, a classic pattern in secondary offerings from smaller-cap growth companies in the defense technology space.

Earnings Miss Adds to the Bearish Backdrop

The offering announcement lands against an already uncertain earnings backdrop. On May 7, 2026, Red Cat reported Q1 fiscal 2026 results that showed $15.5 million in revenue — a record quarter and an extraordinary 849% jump year-over-year, fueled by scaled deliveries under the U.S. Army Short Range Reconnaissance (SRR) program — but still fell short of the FactSet consensus estimate of $17.6 million. The EPS miss was even more severe: the company posted a loss of $0.22 per share, compared to analyst expectations of a $0.10 loss, as operating expenses surged 152% to $29.3 million, driven by sharp increases in R&D, sales and marketing, and G&A costs. Free cash outflow of $31.9 million and a cash balance declining from $167.9 million to $131.9 million during the quarter also flagged burn rate concerns heading into the offering announcement.

Sector Momentum and Contract Win Context

Red Cat has been building an impressive contract portfolio. The company recently won a deal to deliver 173 Black Widow drone systems to Japan's Ministry of Defense, secured new orders from a NATO ally facilitated through the NATO Support and Procurement Agency, and completed the acquisition of swarm robotics firm Apium. These developments speak to strong demand for its defense drone platforms and alignment with the broader global defense spending supercycle. The drone sector has been a market darling on the back of escalating geopolitical tensions and increased government procurement budgets, with defense-focused peers posting outsized gains. However, the stock's ongoing net losses — net loss widened to $26.6 million in Q1 — and the now-confirmed capital raise suggest the growth is coming at a steep cost that the market is increasingly scrutinizing.

Market Context and Trading Activity

Premarket volume in RCAT has already surged significantly relative to its 30-day average premarket volume of approximately 394,000 shares, with over 379,000 shares having changed hands in early premarket hours — an elevated figure consistent with a major corporate event. The stock closed Tuesday at $11.03, itself off 1.96% from the prior session, indicating that selling pressure was building even before the offering news went public. The broader defense ETF space, including names like ITA, will be worth watching during the regular session to assess whether RCAT's move reflects company-specific concerns or a wider sector-level de-risking. The stock's year-to-date gain of approximately 39% heading into Wednesday's session means longer-term holders are still sitting on meaningful profits, which may accelerate selling as they lock in gains into the dilutive offering.

Trending AI Robots

For traders navigating high-volatility events like secondary offerings or earnings reactions in stocks such as RCAT, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers across multiple asset classes, timeframes, and strategies — but only the strongest performers based on current market dynamics are featured in this dedicated Trending section. Each bot is characterized by its traded symbols, risk profile, holding period, and transparent performance metrics, giving traders a clear basis for comparison. Whether you are managing short-term swing trades or seeking systematic exposure to defense and technology trends, exploring the Trending AI Robots page is a sound starting point for integrating data-driven automation into your strategy.

What Comes Next for RCAT

The immediate priority for investors will be the final pricing and terms of the $200 million offering, including the disclosed use of proceeds — whether it targets acquisitions, working capital, SRR program scale-up, or further M&A in the drone ecosystem. Red Cat's next quarterly earnings report is expected around August 24, 2026, where analysts will be watching whether revenue growth is accelerating toward the upper end of contract delivery schedules and whether operating leverage begins to materialize. Contract execution risk remains high: the SRR program has been the engine of growth, and any delivery delays — as seen in prior quarters — could reset investor expectations sharply. Analyst consensus remains constructive, with an average price target of $21.75 from four analysts, though that target will almost certainly be revised following the dilutive offering. Key risks include ongoing net losses, geopolitical disruptions to NATO procurement timelines, integration execution for recently acquired Apium, and competitive pressure from larger defense primes entering the tactical drone market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: RCAT

Momentum Indicator for RCAT turns negative, indicating new downward trend

RCAT saw its Momentum Indicator move below the 0 level on June 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In of the 86 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RCAT moved out of overbought territory on June 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for RCAT turned negative on June 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

RCAT moved below its 50-day moving average on June 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RCAT crossed bearishly below the 50-day moving average on June 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for RCAT moved below the 200-day moving average on June 25, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RCAT entered a downward trend on July 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RCAT advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.845) is normal, around the industry mean (10.542). P/E Ratio (0.000) is within average values for comparable stocks, (93.498). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.141). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (18.116) is also within normal values, averaging (32.047).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.36B. The market cap for tickers in the group ranges from 4.49 to 1.97T. SPCX holds the highest valuation in this group at 1.97T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -4%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -1%. PEW experienced the highest price growth at 23%, while MRLN experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 65
Price Growth Rating: 56
SMR Rating: 79
Profit Risk Rating: 71
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
RCAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
2800 South West Temple
Phone
+1 800 466-9152
Employees
244
Web
https://www.redcat.red
Interact to see
Advertisement
Aon plc (AON) reported third-quarter 2025 revenue of $3.997 billion, representing a 7% year-over-year increase with equal organic growth. Adjusted earnings per share came in at $3.05, exceeding expectations. In late November, Moody’s reaffirmed Aon’s Baa2 credit rating and revised the outlook to positive, citing reduced leverage following the NFP acquisition.
Air Products and Chemicals, Inc. (APD) entered the spotlight after announcing advanced discussions with Yara International on December 8 to collaborate on low-emission ammonia projects. While the strategic direction aligns with global decarbonization trends, uncertainty around execution and capital requirements triggered a 9.45% one-day decline in the stock.
Lockheed Martin and RTX Corporation are two of the most prominent names in the aerospace and defense industry, both positioned to benefit from heightened global security concerns and sustained U.S. military spending.
As 2025 winds down, the Savings Banks sector reflects a mix of stability, innovation, and AI-driven disruption. Among the most closely watched tickers—SOFI Technologies (SOFI), Ally Financial (ALLY), and PayPal Holdings (PYPL)—investors have witnessed contrasting stories of growth, valuation, and market perception.
Ondas Holdings (ONDS) is a wireless technology company focused on delivering secure, long-range communications for industrial Internet of Things (IoT) and data networking applications. Its solutions are built to support mission-critical operations across sectors such as rail, energy, maritime, infrastructure, and industrial automation.
Ciena’s growth is driven by expanding offerings in optical networking, network automation software, and 5G transport infrastructure, complemented by services designed to help customers modernize and future-proof their networks. Its evolving technology portfolio addresses the rising complexity, speed, and reliability requirements of today’s communications environment.
Marathon Digital Holdings (MARA) and Riot Platforms (RIOT) are two leading companies in the Bitcoin mining industry, each operating energy-intensive infrastructure to capitalize on cryptocurrency market cycles. This comparison is especially relevant amid ongoing Bitcoin price volatility and growing interest in digital assets and AI-related infrastructure.
Roivant Sciences has delivered strong year-to-date performance, with shares up roughly 82%, driven by encouraging pipeline developments and increased investment in high-potential subsidiaries such as Immunovant.
MP Materials Corp. (MP) and USA Rare Earth, Inc. (USAR) are central to the United States’ push to establish a secure, domestic supply of rare earth elements—materials critical to electric vehicles, renewable energy, and defense technologies. As geopolitical tensions and supply chain vulnerabilities intensify, these two companies offer distinct approaches to addressing U.S. dependence on foreign sources.
The Invesco QQQ Trust (NASDAQ: QQQ) remains one of the most closely followed ETFs worldwide, offering investors direct exposure to the NASDAQ-100 Index®. In the most recent data, QQQ has gained a notable +20.16% year-to-date, even as markets experienced bouts of elevated volatility.
Sidus Space has expanded its portfolio in 2025, focusing on satellite missions and supporting technologies to enhance space infrastructure. Key product advancements include the LizzieSat platforms, with multiple units progressing in design and manufacturing. LizzieSat-3 is set for launch no earlier than Q1 2025, building on prior missions to boost data capabilities for clients in Earth observation and communication.
As 2025 comes to a close, Dingdong (Cayman) Limited (DDL) continues to strengthen its position in China’s competitive fresh grocery e-commerce market. Operating from Shanghai, the company focuses on high-quality fresh produce, ready-to-eat meals, and daily essentials delivered directly to consumers. Throughout the year, Dingdong emphasized private-label expansion, supply-chain optimization, and fulfillment network growth—initiatives that supported improving quarterly performance and positioned the company for sustained momentum.
Pioneer Power's 2025 highlights include the expansion of its mobile power and charging footprint with new orders and partnerships; the launch of a new suite of e-Boost solutions for off-grid EV charging; the rebranding of HomeBoost as PowerCore with events in December; the introduction of PRYMUS in December; and a new five-year contract for network transformers with a regional utility provider.
An AI-driven comparison between Palantir (PLTR) and Oracle (ORCL) points to Palantir as the more compelling investment heading into 2026. The analysis highlights PLTR’s AI-native platforms, which enable real-time, data-driven decision-making across fast-growing sectors such as government, defense, and enterprise analytics.
An AI-driven comparison between D-Wave Quantum (QBTS) and IonQ (IONQ) points to IonQ as the stronger opportunity heading into 2026. The analysis highlights IONQ’s gate-based, trapped-ion quantum architecture, which supports a wide range of algorithms and positions the company for broader adoption across AI, simulation, and cryptography.
An AI-driven comparison of Rigetti Computing (RGTI) and D-Wave Quantum (QBTS) points to Rigetti as the more compelling opportunity heading into 2026. The analysis highlights RGTI’s gate-based quantum architecture, which supports universal quantum computing and a wide range of complex algorithms. While D-Wave remains a leader in quantum annealing for optimization problems, Rigetti’s full-stack, gate-based approach offers greater scalability and broader long-term applications.
An AI-driven comparison of Rigetti Computing (RGTI) and TeraWulf (WULF) points to TeraWulf as the more attractive investment heading into 2026. The analysis emphasizes WULF’s large-scale digital infrastructure supporting Bitcoin mining and high-performance computing (HPC), which generates immediate revenue in expanding digital asset and AI-driven markets.
An AI-driven comparison between Rocket Lab USA (RKLB) and Planet Labs (PL) identifies Rocket Lab as the more compelling investment heading into 2026. The analysis highlights RKLB’s vertically integrated space services and consistent launch performance, which position the company to benefit from rising demand for satellite deployment and space infrastructure.
An AI-driven comparison of Tempus AI (TEM) and Doximity (DOCS) points to Tempus AI as the more compelling investment opportunity heading into 2026. The analysis highlights TEM’s AI-powered precision medicine platform, which applies advanced analytics and genomic data to transform diagnostics and treatment in oncology and cardiology.